AEPCX
Price
$62.77
Change
+$0.52 (+0.84%)
Updated
Oct 3 closing price
Net Assets
138.77B
AEPFX
Price
$65.63
Change
+$0.54 (+0.83%)
Updated
Oct 3 closing price
Net Assets
138.77B
Interact to see
Advertisement

AEPCX vs AEPFX

Header iconAEPCX vs AEPFX Comparison
Open Charts AEPCX vs AEPFXBanner chart's image
American Funds EUPAC C
Price$62.77
Change+$0.52 (+0.84%)
VolumeN/A
Net Assets138.77B
American Funds EUPAC F2
Price$65.63
Change+$0.54 (+0.83%)
VolumeN/A
Net Assets138.77B
AEPCX vs AEPFX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. AEPFX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and AEPFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX (139B) and AEPFX (139B) have equal amount of cash in the bank . AEPFX pays higher dividends than AEPCX: AEPFX (0.82) vs AEPCX (0.16). AEPCX was incepted earlier than AEPFX: AEPCX (25 years) vs AEPFX (17 years). AEPCX (1.57) is less costly to investors than AEPFX (0.58). AEPCX (35.00) and AEPFX (35.00) have comparable annual turnover. AEPCX (250) and AEPFX (250) have matching initial minimum investment requirements. AEPFX annual gain was more profitable for investors over the last year : 11.74 vs. AEPCX (10.37). AEPFX return over 5 years is better than : 21.12 vs. AEPCX (13.86).
AEPCXAEPFXAEPCX / AEPFX
Total Expense Ratio1.570.58271%
Annual Report Gross Expense Ratio1.570.58271%
Fund Existence25 years17 years-
Gain YTD21.48222.53595%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets139B139B100%
Annual Yield % from dividends0.160.8219%
Returns for 1 year10.3711.7488%
Returns for 3 years42.8248.5388%
Returns for 5 years13.8621.1266%
Returns for 10 years39.9553.9674%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVRD40.232.86
+7.65%
Tvardi Therapeutics Inc
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
GNTA3.30-0.01
-0.25%
Genenta Science SpA
IMCR34.21-1.08
-3.06%
Immunocore Holdings plc
IDCC339.10-17.00
-4.77%
InterDigital